Eye Contact Lens 2021 Apr 26. Epub 2021 Apr 26.
University Hospital of Clermont-Ferrand (V.N., J.-V.B., R.J., A.C., F.C.), CHU Clermont-Ferrand, Ophthalmology, Clermont-Ferrand, France; Université Clermont Auvergne (V.N., F.C.), CNRS UMR 6293, INSERM U1103, Genetic Reproduction and Development Laboratory (GReD), Translational Approach to Epithelial Injury and Repair Team, Clermont-Ferrand, France; The University of Sydney (S.L.W.), Save Sight Institute, Discipline of Ophthalmology, Faculty of Medicine and Health, Sydney, Australia; Sydney Eye Hospital (S.L.W.), Sydney, Australia; University Hospital of Clermont Ferrand (C.L.), CHU Clermont-Ferrand, Clinical Research and Innovation Direction, Clermont-Ferrand, France; and Université Clermont Auvergne (F.D.), CNRS, LaPSCo, Physiological and Psychosocial Stress, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, Preventive and Occupational Medicine, Witty Fit, Clermont-Ferrand, France.
Purpose: To evaluate the outcome of SPOT scleral lenses in the management of irregular astigmatism in patients with corneal ectasia and penetrating keratoplasty. Second, we analyzed patients' characteristics and tolerance, comfort, and geometries of fitted lenses.
Method: Over a 5-year period, we included patients experiencing irregular astigmatism fitted with SPOT scleral contact lenses, from the University Hospital of Clermont-Ferrand, France. Read More